Despite 'Disappointing' Q1 Orders, Accelrys' New CEO Maintains Forecast of Full-Year Revenue Growth

Order intake for the quarter ended June 30 was "disappointing" but Accelrys' new CEO Max Carnecchia said that he is "optimistic" the company will achieve its previously announced full-year 2010 guidance of "low single digit growth" in orders and revenue.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.